Statins & Dementia - The STAREE trial
Quoted:
Statins and Dementia? Well let’s have a look see in a new primary prevention trial of older adults that looked at Dementia risk in addition to cardiac risk.
The new STAREE trial, published in the New England Journal of Medicine, randomized 9,971 adults age 70+ with no known cardiovascular disease, diabetes, or dementia to atorvastatin 40 mg or placebo and followed them for a median of 5.9 years.
This was an investigator-initiated study with no commercial or industry involvement.
The results:
- 30% lower risk of major cardiovascular events with atorvastatin
- 43% lower risk of MI
- 43% lower risk of coronary revascularization
- No significant increase in dementia: HR 1.03
- No significant increase in all-cause mortality
- Serious adverse events: 2.7% in BOTH groups
You’re allowed to dislike statins.
You’re allowed to discuss their limitations and adverse effects.
But you don’t get to invent your own data.
And the claim that statins cause dementia and don’t prevent heart disease is simply not an evidence-based position.
📚 Reference:
Zoungas S, et al. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults. N Engl J Med. 2026;395:1259-1272. DOI: 10.1056/NEJMoa2607314.
#statinsdementiaHD #statinsHD #stareeHD #atorvastatinHD #dementiaHD #alzheimersHD
